Trial Profile

Effect of Prolectin-M; a (1-6)-Alpha-D-Mannopyranose on SarsCoV2 Viral Copy Numbers: A Proof of Concept, Open Label Randomized Controlled Trial

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 04 Jul 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

27 Jun 2023 Results published in the Bioxytran Media Release
29 Mar 2023 According to a Bioxytran media release, company announced, positive data from this clinical trial provided the rationale of dosing and protocol design for study in an upcoming phase 2/3 registrational trial.
29 Mar 2023 According to a Bioxytran media release, company announced, top-line safety and efficacy results of 34 patients from phase 2 portion of this trial published in journal ''Vaccines'' released a peer-reviewed article, ''An Oral Galectin Inhibitor in COVID-19 - A Phase 2 Randomized Controlled Trial''.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com